SMG8 and gastric cancer: Here, we used a positive selection genome-wide CRISPR-Cas9 screen to identify candidate regulators of ATRi resistance in gastric cancer, including loss-of-function mutations in either SMG8 or SMG9 that appeared to cause ATRi resistance by a SMG1-mediated mechanism.